Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/7/03 → 9/10/10 |
Funding
- PPD Development (M02-518 // M02-518)
- Abbott Laboratories (M02-518 // M02-518)
Prot# M02-518: A Phase III Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Subjects with Moderate to Severely Active Psoriatic Arthritis
- Ruderman, Eric M (PD/PI)
Project: Research project